| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Clinical Biochemistry (A.G.N., P.D.O., B.E.C.N.) and Hanson Centre (A.G.N., P.D.O., H.A.M., M.H., B.E.C.N.), Institute of Medical and Veterinary Science and Department of Medicine (A.G.N., H.A.M., M.H., B.E.C.N.), Royal Adelaide Hospital, Adelaide, South Australia 5000
Address all correspondence and requests for reprints to: A/Pr Allan G. Need, Division of Clinical Biochemistry, Institute of Medical and Veterinary Science, Frome Road, Adelaide, South Australia, SA 5000. E-mail: allan.need{at}imvs.sa.gov.au.
It has been known for many years that serum PTH rises with age, and it has been suggested that this rise may contribute to bone loss in postmenopausal women. It has been variously attributed to declining renal function, declining calcium absorption efficiency, and declining serum 25-hydroxyvitamin D [25(OH)D] levels.
We studied the effects of age, weight, renal function, radiocalcium absorption, serum ionized calcium, and serum 25(OH)D on serum PTH levels in 918 postmenopausal women attending an osteoporosis center. On simple linear regression, serum PTH was a positive function of age (P = 0.003) and weight (P < 0.001) and an inverse function of serum 25(OH)D (P < 0.001) and serum ionized calcium (P = 0.002). On stepwise regression, serum 25(OH)D was the most significant (negative) determinant of serum PTH, followed in decreasing order of significance by serum ionized calcium (negative) and body weight and age (positive). Serum PTH was not related to radiocalcium absorption. The reciprocal relation between serum PTH and serum 25(OH)D could not be explained by the serum concentration of 1,25-dihydroxyvitamin D, which did not change with age. After adjustment for serum ionized calcium, body weight, and age, the rise in serum PTH appeared to start when serum 25(OH)D fell less than 80 nmol/liter.
Abbreviations: GFR, Glomerular filtration rate; 25(OH)D, 25 hydroxyvitamin D; 1,25(OH)2D, 1,25-dihydroxyvitamin D; TmP, renal tubular maximum for phosphate reabsorption.
This article has been cited by other articles:
![]() |
B. Dawson-Hughes Serum 25-hydroxyvitamin D and functional outcomes in the elderly Am. J. Clinical Nutrition, August 1, 2008; 88(2): 537S - 540S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Bolland, A. B Grey, R. W Ames, B. H Mason, A. M Horne, G. D Gamble, and I. R Reid The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency Am. J. Clinical Nutrition, October 1, 2007; 86(4): 959 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lappe, K. M. Davies, D. Travers-Gustafson, and R. P. Heaney Vitamin d status in a rural postmenopausal female population. J. Am. Coll. Nutr., October 1, 2006; 25(5): 395 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F Aloia, S. A Talwar, S. Pollack, M. Feuerman, and J. K Yeh Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 602 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Chan and C. J. Rosen Postmenopausal osteoporosis. N. Engl. J. Med., November 3, 2005; 353(18): 1974 - 1975. [Full Text] [PDF] |
||||
![]() |
B.E. C. Nordin and A. G. Need The Relation Between Serum Calcidiol and Calcitriol IBMS BoneKEy, May 1, 2005; 2(5): 7 - 16. [Full Text] [PDF] |
||||
![]() |
J. W Nieves Osteoporosis: the role of micronutrients Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1232S - 1239S. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Nordin, A. G Need, H. A Morris, P. D O'Loughlin, and M. Horowitz Effect of age on calcium absorption in postmenopausal women Am. J. Clinical Nutrition, October 1, 2004; 80(4): 998 - 1002. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |